| Ident. | Authors (with country if any) | Title |
|---|
| 000031 (2021) |
Hülya Gamze Çelik [Turquie] ; Iran Keske [Turquie] ; Ülker Ener [Turquie] ; Müge Tekba [Turquie] ; Mahir Kapmaz [Turquie] ; Krü Taylan Ahin [Turquie] ; Asl Özy Ld R M [Turquie] ; Saide Aytekin [Turquie] ; Vedat Aytekin [Turquie] ; Önder Ergönül [Turquie] | Why we should be more careful using hydroxychloroquine in influenza season during COVID-19 pandemic? |
| 000063 (2021) |
Jennie H. Best [États-Unis] ; Amanda M. Kong [États-Unis] ; Emma Kaplan-Lewis [États-Unis] ; Otis W. Brawley [États-Unis] ; Rachel Baden [États-Unis] ; James L. Zazzali [États-Unis] ; Karen S. Miller [États-Unis] ; James Loveless [États-Unis] ; Krutika Jariwala-Parikh [États-Unis] ; Shalini V. Mohan [États-Unis] | Treatment Patterns in US Patients Hospitalized With COVID-19 and Pulmonary Involvement. |
| 000099 (2021) |
Zelyn Lee [Canada] ; Craig R. Rayner [États-Unis, Australie] ; Jamie I. Forrest [Canada] ; Jean B. Nachega [Afrique du Sud, États-Unis, Canada] ; Esha Senchaudhuri [Canada] ; Edward J. Mills [Canada] | The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19. |
| 000133 (2021) |
Isidro García-Meni O [Espagne] ; Lorena Forcelledo [Espagne] ; Yaiza Rosete [Espagne] ; Emilio García-Prieto [Espagne] ; Dolores Escudero [Espagne] ; Javier Fernández [Espagne] | Spread of OXA-48-producing Klebsiella pneumoniae among COVID-19-infected patients: The storm after the storm. |
| 000158 (2021) |
Hany M. Dabbous [Égypte] ; Manal H. El-Sayed [Égypte] ; Gihan El Assal [Égypte] ; Hesham Elghazaly [Égypte] ; Fatma F S. Ebeid [Égypte] ; Ahmed F. Sherief [Égypte] ; Maha Elgaafary [Égypte] ; Ehab Fawzy [Égypte] ; Sahar M. Hassany [Égypte] ; Ahmed R. Riad [Égypte] ; Mohamed A. Tageldin [Égypte] | Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial. |
| 000163 (2021) |
Tanvir Rahman [États-Unis] ; Quazim A. Alayo [États-Unis] ; Sibgha G. Chaudhary [États-Unis] ; Reihaneh C. Moghadam [États-Unis] ; Matthew L. German [États-Unis] ; Neil A. Ettinger [États-Unis] ; Jeremy E. Leidenfrost [États-Unis] ; Hope A. Cranston-D'Amato [États-Unis] ; Morton R. Rinder [États-Unis] ; Julianne E. Donnelly [États-Unis] | STEMI associated with SARS-CoV-2 infection and the use of ECMO as a potential therapeutic approach in addition to the PCI. |
| 000180 (2021) |
Ilad Alavi Darazam [Iran] ; Shervin Shokouhi [Iran] ; Mohamad Amin Pourhoseingholi [Iran] ; Seyed Sina Naghibi Irvani [Iran] ; Majid Mokhtari [Iran] ; Minoosh Shabani [Iran] ; Mahdi Amirdosara [Iran] ; Parham Torabinavid [Iran] ; Maryam Golmohammadi [Iran] ; Sayedpayam Hashemi [Iran] ; Arsalan Azimi [Iran] ; Mohammad Hossein Jafarazadeh Maivan [Iran] ; Omidvar Rezaei [Iran] ; Alireza Zali [Iran] ; Mohammadreza Hajiesmaeili [Iran] ; Hadiseh Shabanpour Dehbsneh [Iran] ; Akram Hoseyni Kusha [Iran] ; Maryam Taleb Shoushtari [Iran] ; Negar Khalili [Iran] ; Azam Soleymaninia [Iran] ; Latif Gachkar [Iran] ; Ali Khoshkar [Iran] | Role of interferon therapy in severe COVID-19: the COVIFERON randomized controlled trial. |
| 000183 (2021) |
Byung Jin Choi [Corée du Sud] ; Yeryung Koo [Corée du Sud] ; Tae Young Kim [Corée du Sud] ; Wou Young Chung [Corée du Sud] ; Yun Jung Jung [Corée du Sud] ; Ji Eun Park [Corée du Sud] ; Hong-Seok Lim [Corée du Sud] ; Bumhee Park [Corée du Sud] ; Dukyong Yoon [Corée du Sud] | Risk of QT prolongation through drug interactions between hydroxychloroquine and concomitant drugs prescribed in real world practice. |
| 000270 (2021) |
Enrico Scala [Italie] ; Luca Fania [Italie] ; Filippo Bernardini [Italie] ; Rodolfo Calarco [Italie] ; Sabrina Chiloiro [Italie] ; Cristiana Di Campli [Italie] ; Sabrina Erculei [Italie] ; Mauro Giani [Italie] ; Marzia Giordano [Italie] ; Annarita Panebianco [Italie] ; Francesca Passarelli [Italie] ; Andrea Trovè [Italie] ; Sofia Verkhovskaia [Italie] ; Giandomenico Russo [Italie] ; Antonio Sgadari [Italie] ; Biagio Didona [Italie] ; Damiano Abeni [Italie] | Pleomorphicskin eruptions in a COVID-19 affected patient: Case report and review of the literature. |
| 000312 (2021) |
Weerawat Manosuthi [Thaïlande] ; Somlerk Jeungsmarn [Thaïlande] ; Pilailuk Okada [Thaïlande] ; Pawita Suwanvattana [Thaïlande] ; Warawan Wongboot [Thaïlande] ; Unchana Thawornwan [Thaïlande] ; Lantharita Charoenpong [Thaïlande] ; Surasak Wiboonchutikul [Thaïlande] ; Sumonmal Uttayamakul [Thaïlande] ; Wannarat A. Pongpirul [Thaïlande] ; Apichat Wachirapan [Thaïlande] ; Paijit Warachit [Thaïlande] | Nasopharyngeal SARS-CoV-2 Viral Load Response among COVID-19 Patients Receiving Favipiravir. |
| 000332 (2021) |
R K Hussein [Arabie saoudite] ; H M Elkhair [Arabie saoudite, Soudan] | Molecular docking identification for the efficacy of some zinc complexes with chloroquine and hydroxychloroquine against main protease of COVID-19. |
| 000347 (2021) |
Benjamin Coiffard [France] ; Philipp M. Lepper [Allemagne] ; Eloi Prud'Homme [France] ; Florence Daviet [France] ; Nadim Cassir [France] ; Heinrike Wilkens [Allemagne] ; Sami Hraiech [France] ; Frank Langer [Allemagne] ; Pascal A. Thomas [France] ; Martine Reynaud-Gaubert [France] ; Robert Bals [Allemagne] ; Hans-Joachim Sch Fers [Allemagne] ; Laurent Papazian [France] ; Frederik Seiler [Allemagne] | Management of lung transplantation in the COVID-19 era-An international survey. |
| 000428 (2021) |
A A Kamalov [Russie] ; V Yu Mareev [Russie] ; Ya A. Orlova [Russie] ; A G Plisyk [Russie] ; Z A Akopyan [Russie] ; Yu V. Mareev [Royaume-Uni] ; E A Mershina [Russie] ; Yu L. Begrambekova [Russie] ; P V Pakhomov [Russie] | Hydroxychloroquine in patients with novel coronavirus infection (COVID-19): a case-control study. |
| 000437 (2021) |
Hozaifa Khalil Elsawah [Égypte] ; Mohamed Ahmed Elsokary [Égypte] ; Mahmoud Gamal Elrazzaz [Égypte] ; Ahmed Hanei Elshafie [Égypte] | Hydroxychloroquine for treatment of nonsevere COVID-19 patients: Systematic review and meta-analysis of controlled clinical trials. |
| 000491 (2021) |
Gaurav Joshi [Inde] ; Shikha Thakur [Inde] ; Mayank [Inde] ; Ramarao Poduri [Inde] | Exploring insights of hydroxychloroquine, a controversial drug in Covid-19: An update. |
| 000591 (2021) |
Jonne J. Sikkens [Pays-Bas] ; Didier Collard [Pays-Bas] ; Edgar J G. Peters [Pays-Bas] | Comparison of hospital treatment strategy or of treatment actually received in COVID-19?: Commenting on: Lammers AJJ, Brohet RM, Theunissen REP, Koster C, Rood R, Verhagen DWM, et al. Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients. Int J Infect Dis. 2020 September. |
| 000603 (2021) |
Hao-Yu Wu [Taïwan] ; Chien-Ting Pan [Taïwan] ; Chiao-Feng Cheng [Taïwan] ; Chi-Ying Lin [Taïwan] ; Sheng-Nan Chang [Taïwan] ; Yi-Chung Chen [Taïwan] ; Chih-Yuan Wang [Taïwan] ; Yen-Fu Chen [Taïwan] ; Chung-Yu Chen [Taïwan] ; Matthew Huei-Ming Ma [Taïwan] ; Juey-Jen Hwang [Taïwan] | Combined intravenous immunoglobulin and baricitinib treatment for severe COVID-19 with rhabdomyolysis: A case report. |
| 000610 (2021) |
Majid Mokhtari [Iran] ; Minoo Mohraz [Iran] ; Mohammad Mehdi Gouya [Iran] ; Hengameh Namdari Tabar [Iran] ; Jafar-Sadegh Tabrizi [Iran] ; Katayoun Tayeri [Iran] ; Saeide Aghamohamadi [Iran] ; Zahra Rajabpoor [Iran] ; Manoochehr Karami [Iran] ; Alireza Raeisi [Iran] ; Hamid Rahmani [Iran] ; Hossein Khalili [Iran] | Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting. |
| 000624 (2021) |
Saleh Alghamdi [Arabie saoudite] ; Bassant Barakat [Arabie saoudite] ; Ilhem Berrou [Royaume-Uni] ; Abdulhakim Alzahrani [Arabie saoudite] ; Abdul Haseeb [Arabie saoudite] ; Mohamed Anwar Hammad [Arabie saoudite] ; Sirajudheen Anwar [Arabie saoudite] ; Abdulmajeed Abdulghani A. Sindi [Arabie saoudite] ; Hussain A. Almasmoum [Arabie saoudite] ; Mohammad Albanghali [Arabie saoudite] | Clinical Efficacy of Hydroxychloroquine in Patients with COVID-19: Findings from an Observational Comparative Study in Saudi Arabia. |
| 000635 (2021) |
Edward J. Calabrese [États-Unis] ; Jaap C. Hanekamp [Pays-Bas] ; Yannic N. Hanekamp [Pays-Bas] ; Rachna Kapoor [États-Unis] ; Gaurav Dhawan [États-Unis] ; Evgenios Agathokleous [République populaire de Chine] | Chloroquine commonly induces hormetic dose responses. |
| 000675 (2021) |
Hormat Rahimzadeh [Iran] ; Mohammad Keykhaei [Iran] ; Effat Razeghi [Iran] ; Ensieh Zivari [Iran] ; Ensieh Sadat Mansouri [Iran] | COVID-19 progression in kidney transplant recipients: a single-center case series. |
